- Home
- STR vs LMAT Comparison
STR vs LMAT Comparison
Compare STR & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STR
- LMAT
- Stock Information
- Founded
- STR 2016
- LMAT 1983
- Country
- STR United States
- LMAT United States
- Employees
- STR N/A
- LMAT N/A
- Industry
- STR Oil & Gas Production
- LMAT Medical/Dental Instruments
- Sector
- STR Energy
- LMAT Health Care
- Exchange
- STR Nasdaq
- LMAT Nasdaq
- Market Cap
- STR 1.4B
- LMAT 1.9B
- IPO Year
- STR N/A
- LMAT 2006
- Fundamental
- Price
- STR $18.61
- LMAT $83.69
- Analyst Decision
- STR Buy
- LMAT Buy
- Analyst Count
- STR 6
- LMAT 6
- Target Price
- STR $25.60
- LMAT $100.80
- AVG Volume (30 Days)
- STR 1.5M
- LMAT 152.3K
- Earning Date
- STR 08-06-2025
- LMAT 08-05-2025
- Dividend Yield
- STR 7.83%
- LMAT 0.93%
- EPS Growth
- STR N/A
- LMAT 30.45
- EPS
- STR 0.52
- LMAT 1.97
- Revenue
- STR $636,538,000.00
- LMAT $226,256,000.00
- Revenue This Year
- STR N/A
- LMAT $13.88
- Revenue Next Year
- STR N/A
- LMAT $8.81
- P/E Ratio
- STR $35.71
- LMAT $42.49
- Revenue Growth
- STR 7.18
- LMAT 13.19
- 52 Week Low
- STR $14.58
- LMAT $71.42
- 52 Week High
- STR $25.64
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- STR 50.57
- LMAT 50.89
- Support Level
- STR $17.60
- LMAT $82.76
- Resistance Level
- STR $18.37
- LMAT $86.94
- Average True Range (ATR)
- STR 0.57
- LMAT 2.10
- MACD
- STR -0.11
- LMAT 0.18
- Stochastic Oscillator
- STR 47.53
- LMAT 47.92
About STR Sitio Royalties Corp.
Sitio Royalties Corp is a pure-play mineral and royalty company. The group focuses on investing in mineral and royalty interests in the Permian and other productive U.S. oil basins.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.